Fol. Biol. 2022, 68, 78-85

https://doi.org/10.14712/fb2022068020078

MicroRNA-214-3p Ameliorates LPS-Induced Cardiomyocyte Injury by Inhibiting Cathepsin B

W. Yan, Y. Feng, Z. Lei, W. Kuang, Chaozhong Long

The First Affiliated Hospital, Department of Cardiovascular Surgery, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China

Received April 2022
Accepted August 2022

Crossref Cited-by Linking

  • Zhao Dandan, Ji Hao, Zhang Weijia, He Anni, Guo Caizhe, Ma Li, Liu Yan: miR-214-3p inhibits LPS-induced macrophage inflammation and attenuates the progression of dry eye syndrome by regulating ferroptosis in cells. Genes Genom 2024. <https://doi.org/10.1007/s13258-024-01598-4>
  • Huang Xianggui, Zheng Danling, Liu Chong, Huang Jianxiang, Chen Xiaoshan, Zhong Jialin, Wang Jing, Lin Xinyue, Zhao Chengkuan, Chen Meini, Su Siman, Chen Yun, Xu Chengcheng, Lin Chaoxian, Huang Yihui, Zhang Shuyao: miR-214 could promote myocardial fibrosis and cardiac mesenchymal transition in VMC mice through regulation of the p53 or PTEN-PI3K-Akt signali pathway, promoting CF proliferation and inhibiting its ng pathway. International Immunopharmacology 2023, 124, 110765. <https://doi.org/10.1016/j.intimp.2023.110765>
  • Su Jingqian, Wu Shun, Zhou Fen, Tong Zhiyong: Research Progress of Macromolecules in the Prevention and Treatment of Sepsis. IJMS 2023, 24, 13017. <https://doi.org/10.3390/ijms241613017>
Crossref Cited-by Linking logo